Home » Topics » Regulatory

Regulatory
RSS

FDA advisory committee to review finasteride for alopecia

Oct. 22, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

FDA clears generic transdermal nicotine product

Oct. 22, 1997

Further indications of divalproex efficacy in dementia

Oct. 21, 1997

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Andrx's Diltia XT approved and launched in U.S.

Oct. 20, 1997

Shire files IND for new formulation of aciclovir

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Nascobal introduced in U.S., licensed to Meda for Nordic countries

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Flow Neuro wins FDA nod for at-home device for depression
BioWorld MedTech
Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...